(Q42981053)

12 November 2017

0 references

Predictors of response to interferon therapy (English)

1 reference

12 November 2017

G Saracco

1

1 reference

12 November 2017

M Rizzetto

series ordinal

2

1 reference

12 November 2017

publication date

1 December 1996

1 reference

Digestive Diseases and Sciences

12 November 2017

published in

1 reference

12 November 2017

volume

41

1 reference

12 November 2017

issue

12 Suppl

1 reference

12 November 2017

page(s)

115S-120S

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02087886

12 November 2017

exact match

0 references

cites work

Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02087886

Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment

21 January 2018

1 reference

12 December 2020

Continuous versus intermittent therapy for chronic hepatitis C with recombinant interferon alfa-2a

1 reference

12 December 2020

Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection

1 reference

12 December 2020

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

1 reference

12 December 2020

Factors useful in predicting the response to interferon therapy in chronic hepatitis C.

1 reference

12 December 2020

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients

1 reference

12 December 2020

Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction.

1 reference

12 December 2020

Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response

1 reference

12 December 2020

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

12 December 2020

Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II.

1 reference

12 December 2020

Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b.

1 reference

12 December 2020

Response to interferon alpha therapy is influenced by the iron content of the liver

1 reference

12 December 2020

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

1 reference

12 December 2020

Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. The TVVH Study Group.

1 reference

12 December 2020

Benelux multicentre trial of alpha interferon treatment for chronic hepatitis C: standard v high dose treatment monitored by biochemical and virological markers (interim analysis). Benelux Multicentre Trial Study Group

1 reference

12 December 2020

Long-term follow-up of patients with chronic hepatitis C treated with α-interferon

1 reference

12 December 2020

A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis

1 reference

12 December 2020

Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus

1 reference

12 December 2020

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

1 reference

12 December 2020

Hepatitis C virus after interferon treatment has the variation in the hypervariable region of envelope 2 gene

1 reference

12 December 2020

Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease

1 reference

12 December 2020

Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.

1 reference

12 December 2020

High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial

1 reference

12 December 2020

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

12 December 2020

Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C

1 reference

12 December 2020

Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience

1 reference

12 December 2020

A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody.

1 reference

12 December 2020

Reliability of polymerase chain reaction for detection of hepatitis C virus

1 reference

12 December 2020

Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha

1 reference

12 December 2020

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.

1 reference

12 December 2020

Hepatitis C virus genetic variability: clinical implications

1 reference

12 December 2020

Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.

1 reference

12 December 2020

Factors predictive of the response to interferon in patients with chronic hepatitis C

1 reference

12 December 2020

Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France

1 reference

12 December 2020

Prolonged treatment (18 months) of chronic hepatitis C with recombinant alpha-interferon in comparison with a control group

1 reference

12 December 2020

Factors predicting early response to treatment with recombinant interferon alpha-2a in chronic non-A, non-B hepatitis. Preliminary report of a long-term trial

1 reference

12 December 2020

Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. The TriVeneto Viral Hepatitis Group

1 reference

12 December 2020

Alpha interferon in the treatment of chronic hepatitis C infection in thalassaemia major

1 reference

12 December 2020

Prediction of interferon effect in chronic hepatitis C by both quantification and genotyping of HCV-RNA.

1 reference

12 December 2020

Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo

1 reference

12 December 2020

Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection

1 reference

12 December 2020

Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C

1 reference

12 December 2020

Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon

1 reference

12 December 2020

Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants

1 reference

12 December 2020

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.

1 reference

12 December 2020

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

1 reference

12 December 2020

Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment

1 reference

12 December 2020

The hypervariable region of the HCV genome changes sequentially during the progression of acute HCV infection to chronic hepatitis

1 reference

12 December 2020

Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial.

1 reference

12 December 2020

Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer

1 reference

12 December 2020

Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy

1 reference

12 December 2020

High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks

1 reference

12 December 2020

High dose interferon treatment in chronic hepatitis C.

1 reference

12 December 2020

Treatment of chronic hepatitis C with recombinant human interferon-alpha 2a: results of a randomized controlled clinical trial

1 reference

12 December 2020

Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment

1 reference

12 December 2020

Prediction of response to interferon treatment of chronic hepatitis C.

1 reference

12 December 2020

Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes

1 reference

12 December 2020

Hepatitis C virus genotype and RNA titer in the progression of type C chronic liver disease

1 reference

12 December 2020

Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection

1 reference

12 December 2020

The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02087886

1 reference

release_rbhkqtukxfcz5jqo43y6qaea2e

12 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rbhkqtukxfcz5jqo43y6qaea2e

24 November 2022

mapped directly with Wikidata item

1 reference